Centrus Energy Corp. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2014. USEC Inc. emerged from Chapter 11 on September 30 and changed its name to Centrus Energy Corp. Fresh start accounting created a new reporting entity; accordingly, results through September 30 are predecessor results and are not directly comparable with the successor balance sheet or future results.
Business context and financial performance
Centrus supplies low-enriched uranium (LEU) to nuclear utilities. After ending enrichment at Paducah in May 2013, it is relying on inventory, Russian supply purchases and other potential suppliers. The Paducah facilities were returned to DOE on October 21, 2014, after quarter-end. The American Centrifuge project continued under a reduced-scope, fixed-price contract with UT-Battelle/ORNL.
| Metric (USD millions, except per-share data) | Three months ended Sep. 30, 2014 | Nine months ended Sep. 30, 2014 | Prior-year comparable period |
|---|---|---|---|
| Revenue | 120.7 | 390.5 | 303.8 / 909.0 |
| Gross profit (loss) | (5.4) | (22.8) | (30.0) / (63.6) |
| Operating loss | (16.4) | (74.3) | (53.3) / (135.0) |
| Net income (loss) | 418.9 | 340.1 | (44.3) / (87.2) |
| Operating cash flow | Not separately presented | (220.3) | (104.6) for nine months |
Reported net income primarily reflects non-cash reorganization and fresh-start gains, not profitable ongoing operations. Reorganization items were a net credit of $440.0 million for the quarter and $426.9 million year to date. The reported gross margin was negative 4.5% for the quarter and negative 5.8% year to date; the prior-year margins were negative 9.9% and negative 7.0%, respectively.
- Revenue fell 60% in the quarter and 57% year to date. LEU-segment revenue declined 67% and 61%, respectively, mainly because SWU delivery volumes fell; average billed SWU prices rose modestly. No uranium revenue was recorded in 2014.
- Contract-services revenue rose to $23.3 million for the quarter and $43.0 million year to date, including work under the ACTDO Agreement. Reduced Paducah transition costs and lower advanced-technology spending improved reported losses, but gross profit remained negative.
- Cash and cash equivalents were $105.4 million at September 30, down from $314.2 million at December 31, 2013. Operating cash use included a $293.4 million reduction in Russian-contract payables, partly offset by a $177.0 million inventory reduction. Investing activities provided $12.3 million and financing used $0.8 million over nine months.
Financial position, restructuring and material changes
- At September 30, total assets were $1,063.6 million, total liabilities $1,004.3 million, and stockholders’ equity $59.3 million. Current assets were $716.4 million and current liabilities $327.0 million; reported working capital was $389.4 million. Comparisons with December 2013 are affected by bankruptcy restructuring and fresh start accounting.
- The old $530 million convertible notes and convertible preferred stock were cancelled. Centrus issued $240.4 million of 8% PIK toggle notes due 2019, with an extension option to 2024 subject to funding conditions. It elected to pay 3% annual interest in kind for the first two interest periods; later it may elect to pay up to 5.5% in kind. The notes were issued for claims, not for cash.
- Centrus also obtained a $48.0 million secured intercompany note from Enrichment Corp., payable on demand and bearing 10.5% interest, to fund plan payments and working capital. The former $110 million credit facility had matured in 2013 and was not replaced.
- Fresh start accounting estimated enterprise value at $299.7 million and recorded $123.5 million of identifiable intangible assets and $137.2 million of excess reorganization value. Inventory was increased by $35.4 million; pension and postretirement obligations were remeasured upward. These estimates depend on projections and valuation assumptions.
- The restructuring issued 9 million new shares. Former noteholders received most of the new equity; strategic investors Babcock & Wilcox and Toshiba received Class B shares with rights to elect two directors in aggregate. The old shares were cancelled.
Outlook, management commentary and principal risks
- Management expected 2014 sales volume to be about 30% of the 2008–2012 annual average of approximately 11 million SWU, with future sales constrained by available supply. It expected year-end 2014 cash above $150 million, compared with $105.4 million at September 30. These are expectations, not guarantees.
- Management stated that current LEU oversupply and SWU prices—then at their lowest levels in more than a decade—made prior commercial deployment plans for the American Centrifuge project uneconomic without additional government support. It continued to preserve the option to deploy the technology.
- The ACTDO contract was extended through March 31, 2015, raising its value to approximately $75.3 million; an additional six-month option would add approximately $41.7 million. Current allotted funds covered work through November 30, 2014. Further government funding and continuation beyond the contract remain uncertain. Management estimated about $11 million in additional demobilization costs through first-quarter 2015.
- Approximately 30% of the LEU sales backlog remained at risk from American Centrifuge financing or deployment milestones. Customer contract changes, order timing, Russian supply pricing and import limits, and the ability to source alternative LEU could affect revenue, margins and liquidity.
- Defined-benefit pension and postretirement obligations were $174.1 million and $211.6 million, respectively, on the balance sheet. Centrus disputed the PBGC’s preliminary estimate of approximately $130 million of potential Portsmouth-related ERISA Section 4062(e) liability; potential Paducah-related liability could be greater. PBGC actions could require additional funding, security, or plan termination.
- DOE receivables remain uncertain: approximately $75 million of overdue invoices related to filed claims were outstanding at September 30, while the recognized long-term receivable was $19.8 million. DOE denied a separate $42.8 million pension-cost claim; Centrus intended to appeal. Collection timing and amounts are uncertain.
- Subsequent to quarter-end, CEO John K. Welch left on October 17. The company named John R. Castellano interim CEO and disclosed approximately $3.3 million of fourth-quarter severance-related expense, plus $0.2 million of deferred bonus payable in first-quarter 2015.
Most important facts for investors to verify
- Whether the expected year-end cash balance above $150 million was achieved and whether operating cash use remains manageable without a credit facility.
- Whether ACTDO funding continued beyond November 30, 2014, and whether government appropriations or the remaining contract option supported the centrifuge program.
- Progress in revising at-risk customer contracts, preserving backlog, and matching Russian and other supply commitments to customer demand and import restrictions.
- Developments in PBGC discussions and any resulting pension funding, lien, security or plan-termination obligations, including potential Paducah exposure.
- Outcomes and cash-collection timing for DOE claims, including the disputed pension-cost claim and the recognized value of long-dated receivables.
- Fresh-start valuation assumptions, subsequent intangible-asset amortization or impairment, and the distinction between reorganization-driven reported earnings and recurring operating performance.